The Mag

Sepsis, Exosomes, Longevity, Bioeconomy

In this issue:

  • Sepsis: Targeting a silent killer
  • Exosomes: Nanovesicles take personalised medicine to the next level
  • Longevity: Endogenous biomarker points to an increased life expectancy
  • Bioeconomy: Can carbon dioxide emissions act as a feedstock for industry?
  • Interview with Hans-Georg Eichler, EMA‘s Senior Medical Officer
  • News from our partner associations European Biotechnology Network, EAPB, EDMA, DIA, BIO Deutschland and the Swiss Biotech Association
  • ... and our Special CROs & CMOs.